Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1

Por: Lu, YS, Chiu, J, Airoldi, M, Vila, MM, Lorenzo, JP, Ghaznawi, F, Gaudenzi, F, Ridolfi, A, Lorenzo, I and Borrego, MR

---

Publicada: 1 sep 2020

---

---

Filiaciones:
Lu, YS:
 Natl Taiwan Univ Hosp, Med Oncol, Taipei, Taiwan

Chiu, J:
 Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

Airoldi, M:
 San Giovanni Battista Hosp, Dept Med Oncol, Turin, Italy

:
 Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain

Lorenzo, JP:
 Univ Gen Hosp Alicante, Dept Med Oncol, Alicante, Spain

Ghaznawi, F:
 Novartis Pharmaceut, Oncol, E Hanover, NJ USA

Gaudenzi, F:
 Novartis Pharma AG, Oncol, Basel, Switzerland

Ridolfi, A:
 Novartis Pharma SAS, Oncol, Paris, France

Lorenzo, I:
 Novartis Pharma SAS, Oncol, Paris, France

Borrego, MR:
 Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain